The expression of matrix metalloproteinase-13 (MMP-13) on xenograft and PRF in bone regeneration / Efeito da combinação de xenoenxerto e PRP na expressão de metaloproteinase de matriz -13 (MMP-13) durante regeneração óssea

Objective: inflammation may play a role in bone loss by altering the boné remodelling process, favouring bone resorption by osteoclasts over bone synthesis by osteoblasts. Matrix metalloproteinase 13 (MMP-13) has the ability to activate osteoclasts, leading to bone resorption. Regenerative treatments have been widely used in periodontology. When combined with Platelet-rich fibrin (PRF), xenografts will give better results in bone regeneration. The aim of this study was to evaluate the effect of xenograft combined with PRF on MMP-13 expression in a bone defect using an experimentally created bone defect. Material and Methods: eighteen New Zealand rabbits were assigned to three groups. Each group consisted of six New Zealand rabbits. A critical bone defect with a diameter size of 5 mm was created in the right tibia of each rabbit in group 1 (application: xenograft), group 2 (application: PRF), and group 3 (application: xenograft and PRF). The PRF was produced from 5 ml of blood taken from each rabbit's ears. After 30 days, the rabbits were euthanized. The tissue samples were evaluated by immunohistochemical staining. Results: group 3 showed the lowest mean expression of MMP-13 (4.50) compared to group 1 (20.50) and group 2 (11.70). Group 3 showed a significant difference in the MMP-13 expression compared to group 1 and group 2 (P = 0.000) (P < 0.05). Conclusion: this research showed that the combination of xenograft and PRF had the lowest expression of MMP-13. The application of a xenograft and PRF has better osteogenesis ability in bone regeneration.(AU)

Objetivo: inflamação pode interferir na perda óssea através de alterações no processo de remodelação, favorecendo a reabsorção óssea pelos osteoclastos ao invés da síntese pelos osteoblastos. A metaloproteinases de matriz 13 (MMP-13) ativa osteoclastos causando reabsorção óssea. Tratamentos regenerativos têm sido amplamente usados na periodontia. Quando combinamos Plasma rico em plaquetas (PRP) e xenoenxerto levam a melhores resultados de regeneração óssea. O objetivo deste estudo foi avaliar os efeitos de xenoenxerto combinado com PRP na expressão de MMP-13 em defeitos ósseos experimentais. Material e Métodos: dezoitos coelhos Nova Zelândia foram distribuídos em 3 grupos de 6 coelhos cada. Um defeito ósseo de 5 mm de diâmetro foi feito na tíbia direita dos animais do grupo 1 (xenoenxerto), grupo 2 (PRP) e grupo 3 (Xenoenxerto+PRP). O PRP foi obtido pela coleta de 5mL de sangue das orelhas dos coelhos. Após 30 dias, os coelhos foram eutanasiados. As amostras foram submetidas a coloração imuno-histoquímica. Resultados: o grupo 3 apresentou a menor expressão de MMP-13 (4.50) quando comparado ao grupo 1 (20.50) e ao grupo 2 (11.70). O grupo 3 mostrou diferença estatística significante em relação a expressão de MMP-13 quando comparado aos grupos 1 e 2 (p=0.000) (p< 0.05). Conclusão: esta pesquisa mostra que a combinação de xenoenxerto e PRP teve a menor expressão de MMP-13. A combinação de xenoenxerto e PRP têm maior habilidade de osteogênese na regeneração óssea (AU)

Primary cultures of mouse small intestinal epithelial cells using the dissociating enzyme type I collagenase and hyaluronidase

The epithelium is a highly dynamic system, which plays a crucial role in the homeostasis of the intestinal tract. However, studies on the physiological and pathophysiological functions of intestinal epithelial cells (IECs) have been hampered due to lack of normal epithelial cell models. In the present study, we established a reproducible method for primary culture of mouse IECs, which were isolated from the viable small intestinal crypts of murine fetuses (on embryonic day 19), using type I collagenase and hyaluronidase in a short span of time (≤20 min). With this method, continuously growing mouse IECs, which can be subcultured over a number of passages, were obtained. The obtained cell lines formed a tight cobblestone-like arrangement, displayed long and slender microvilli, expressed characteristic markers (cytokeratin 18 and Notch-1), and generated increasing transepithelial electrical resistance and low paracellular permeability during in vitro culture. The cells also had enzymatic activities of alkaline phosphatase and sucrase-isomaltase, and secreted various cytokines (IL-1β, IL-6, IL-8, and monocyte chemoattractant protein-1), responding to the stimulation of Escherichia coli. These results show that the primary-cultured mouse IECs obtained by the method established here had the morphological and immunological characteristics of IECs. This culture system can be a beneficial in vitro model for studies on mucosal immunology and toxicology.

Etanercept protects rat cardiomyocytes against hypertrophy by regulating inflammatory cytokines secretion and cell apoptosis

We aimed to investigate the effect of etanercept, a tumor necrosis factor-α (TNF-α) inhibitor, on rat cardiomyocyte hypertrophy and its underlying mechanism. Primary neonatal rat cardiomyocytes were isolated from Sprague-Dawley rats. The model of rat cardiomyocyte hypertrophy was induced by endothelin, and then treated with different concentrations of etanercept (1, 10, and 50 μM). After treatment, cell counts, viability and cell apoptosis were evaluated. The mRNA levels of myocardial hypertrophy marker genes, including atrial natriuretic factor (ANF), matrix metalloproteinase (MMP)-9 and MMP-13, were detected by qRT-PCR, and the expressions of apoptosis-related proteins (Bcl-2 and Bax) were measured by western blotting. The protein levels of transforming growth factor-β1 (TGF-β1), interleukin (IL)-1β, IL-6, leukemia inhibitory factor (LIF) and cardiotrophin-1 (CT-1) were determined using enzyme linked immunosorbent assay (ELISA) kits. In the present study, TNF-α level in cardiomyocytes with hypertrophy was significantly enhanced (P<0.05). Compared to the model group, cell number and viability were significantly increased and ratio of apoptotic cells was reduced by etanercept (P<0.05, P<0.01, or P<0.001). In addition, etanercept remarkably reduced the mRNA levels of ANF, MMP-9 and MMP-13, inhibited the expression of Bax, and increased the expression of Bcl-2 compared to the model group (P<0.05). ELISA results further showed that etanercept lowered the levels of IL-1β, IL-6, LIF and CT-1 but not TGF-β1 compared to the model group (P<0.05). Etanercept may protect rat cardiomyocytes from hypertrophy by inhibiting inflammatory cytokines secretion and cell apoptosis.

MMP13, TIMP2 and TGFB3 Gene Polymorphisms in Brazilian Chronic Periodontitis and Periimplantitis Subjects

Abstract Subjects susceptible to chronic periodontitis (CP) show a high risk for the development of peiimplantitis (PI). Both diseases are multifactorial, presenting similarities in their pathophysiology and polygenic profile. MMP-13 (matrix metalloproteinases 13/ collagenase 3) is a collagenolytic enzyme, which expression is induced by TGF beta 3 (transforming growth factor type 3) in human gingival fibroblasts and inhibited by TIMP-2 (tissue inhibitor of metalloproteinase type 2). The aim of this study was to investigate the occurrence of peiimplantitis (PI) in subjects with history of chronic periodontitis (CP) and polymorphisms frequency in MMP13, TIMP2 and TGFB3 genes. One hundred and sixty-three volunteers received dental implant placement were submitted to oral and radiographic examination in order to identify past history of CP or presence of PI. Volunteers were divided into 4 groups: Control (without PI and CP, n=72), CP (with CP and without PI, n=28), PI (with PI and without CP, n=28) and diseased (with CP and PI, n=35). The chi-square test correlated genotypes in specific regions of MMP13 (rs2252070), TIMP2 (rs7501477) and TGFB3 (rs2268626) genes, considering the interaction between CP and PI. The results showed that volunteers with CP had 3.2 times more susceptibility to develop PI (p=0.0004) compared to those without CP. No significant association was observed in MMP13, TIMP2 and TGFB3 genes with CP or PI. CP is a risk factor to develop PI, however, there is no association of both diseases with polymorphisms in the MMP13, TIMP2 and TGFB3 genes.

Resumo Indivíduos susceptíveis à periodontite crônica (CP) apresentam alto risco para o desenvolvimento de periimplantite (PI). Ambas doenças são multifatoriais e apresentam similaridades na patofisiologia e perfil poligênico. A MMP-13 (metaloproteinase da matriz tipo 13) é uma enzima colagenolítica cuja expressão é induzida por TGF beta 3 (fator transformador do crescimento tipo 3) nos fibroblastos gengivais humanos e inibida por TIMP-2 (inibidor tecidual de metaloproteinase tipo 2). O objetivo deste estudo foi investigar a ocorrência de periimplantite em sujeitos com periodontite crônica e a frequência dos polimorfismos nos genes MMP13, TIMP2 e TGFB3. Cento e sessenta e três voluntários submetidos à instalação de implantes endósseos foram analisados clínica e radiograficamente quanto à presença de histórico de CP e PI, sendo divididos em 4 grupos: Controle (sem história de CP e PI, n=72), CP (com CP e sem PI, n=28), PI (com PI e sem CP, n=28) e Doentes (com CP e PI, n=35). O teste do qui-quadrado correlacionou os genótipos nas regiões dos genes MMP13 (rs2252070), TIMP2 (rs7501477) e TGFB3 (rs2268626), considerando a interação entre CP e PI. Os resultados mostraram que voluntários com CP possuem 3.2 vezes mais chances de desenvolver PI (p=0.0004) comparados aos sem CP. Nenhuma associação significativa foi observada entre os genes MMP13, TIMP2 e TGFB3 e CP ou PI. A CP é um fator de risco ao desenvolvimento de PI, no entanto, não há associação entre ambas as doenças com polimorfismos nos genes MMP13, TIMP2 e TGFB3.

The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis

BACKGROUND: Osteoarthritis (OA) is a common arthritic disease and multifactorial whole-joint disease. Interactions of chemokines and OA is inadequately documented. RESULTS: In vivo and in vitro studies were conducted to investigate monocyte chemoattractant protein 1 (MCP-1) and receptor chemokine (C-C motif) receptor 2 (CCR2) in chondrocyte degradation and cartilage degeneration. Chondrocytes from 16 OA patients and 6 normal controls were involved in this study. After stimulation of MCP-1, the expression of MCP-1 and CCR2 increased significantly (P < 0.001) and the expression of MMP-13 also increased (P < 0.05). MCP-1 stimulation also induced (or enhanced) the apoptosis of OA chondrocytes (P < 0.05). Additionally, the degradation of cartilage matrix markers (metalloproteinase 3 and 13, MMP3 and MMP13) in the culture medium of normal chondrocytes was also assessed. Furthermore, intra-articular injection of MCP-1 in mouse knees induced cartilage degradation and the CCR2 antagonist did not impede cartilage destroy in rats knees of monosodium iodoacetate (MIA) model. CONCLUSIONS: The results of this study demonstrate that the MCP-1-CCR2 ligand-receptor axis plays a special role in the initiation and progression of OA pathology. Patients with ambiguous etiology can gain some insight from the MCP-1-CCR2 ligand-receptor axis.

Valor prognóstico dos polimorfismos funcionais nos genes da mmp-1, mmp-13 e IL-8 no carcinoma epidermóide oral e de orofaringe / Prognostic value of functional polymorphisms in the mmp-1, mmp-13 and IL-8 genes in oral and oropharyngeal squamous cell carcinoma

Tumores malignos tem a habilidade de invadir tecidos normais e de se espalharem para sítios anatômicos distantes, originando, a metástase o maior fator de mortalidade do câncer. As metaloproteinases de matriz (MMP)-1 e MMP-13 tem sido associada a invasão tumoral e a metástase, pois a MMP-1 degrada colágeno tipo I, que é o substrato mais abundante no estroma tumoral e a MMP-13 degrada coágeno tipo IV, dentre outros , que está presente na membrana basal dos vasos. Pesquisas mostram que a IL-8 é um potente fator angiogênico e está associada ao crescimento tumoral, à metástase e ao pobre prognóstico do câncer. O presente trabalho se propõe a verificar a existência e a frequências dos polimorfismos nos genes das MMPs-1(rs2071230 e rs470558), -13(rs2252070) e da IL-8 (rs4073 e rs2227532) e investigar o possivel valor prognósticos dos mesmo em uma serie de casos de carcinoma epidermoide oral e de orofaringe(CEOO). Foram genotipados por meio de PCR em tempo real 98 amostra de pacientes com carcinoma epidermóide e 134 amostras controle (AU).

Expressão de MMP-13 e ativação de vias de sinalização intracelular em dois modelos de doença periodontal induzida experimentalmente em ratos / MMP-13 expression and signaling pathways activated in two models of experimentally-induced periodontal disease in rats

A progressão da doença periodontal é marcada pela excessiva produção de citocinas que, por sua vez, promove o aumento de outros mediadores inflamatórios, entre os quais, de metaloproteinases de matriz (MMPs). MMP-13 é uma colagenase de regulação complexa que tem sido relacionada à degradação da matriz extracelular (ECM) e à reabsorção óssea em diversas condições inflamatórias, incluindo doença periodontal e artrite reumatóide. A regulação da expressão gênica requer a ativação de várias vias de sinalização através da interação de receptores celulares específicos a estímulos externos, como antígenos bacterianos e citocinas derivadas do hospedeiro. A complexidade da rede de citocinas estabelecida durante a progressão da doença periodontal depende das vias de sinalização ativadas, as quais são influenciadas pela natureza do estímulo extracelular. Considerando o papel fundamental das vias de sinalização no controle da expressão gênica de citocinas e a relevante atividade de MMP-13 na doença periodontal, este estudo avaliou a expressão de MMP-13 e as vias de sinalização ativadas durante o curso de dois modelos de doença periodontal induzida experimentalmente. A expressão de MMP-13 nos níveis de RNA mensageiro (mRNA) e proteína foram avaliados por RT-PCR e Western Blot, respectivamente. A cinética de ativação das vias de sinalização intracelular relacionadas à expressão de mediadores inflamatórios também foi verificada por Western Blot. Estes achados foram relacionados à severidade da reação inflamatória determinada por estereometria. Dois modelos experimentais foram usados: injeção de LPS e colocação de ligadura. Injeções de LPS de Eschericia coli foram realizadas na região palatina de molares superiores 2 vezes por semana (30 µg por aplicação). Ligaduras foram colocadas na região cervical dos primeiros molares inferiores. O grupo controle recebeu injeções de PBS (veículo) na gengiva palatina dos primeiros molares superiores, enquanto ligaduras não foram colocadas nos molares inferiores. Amostras foram coletadas 5, 15 e 30 dias após a indução da doença periodontal e processadas para extração de RNA total e proteína, assim como rotineiramente processadas para análise histológica/estereométrica. Um aumento significante da severidade da inflamação foi observado em ambos os modelos já no período de 5 dias. Entretanto, o modelo de ligadura mostrou uma diminuição da intensidade da inflamação aos 30 dias, que não foi observada no modelo de injeção de LPS. O perfil de expressão dos níveis de mRNA de MMP-13, assim como a cinética das vias de sinalização ativadas durante o curso da doença periodontal foram distintos segundo o modelo experimental mas, em geral, acompanharam a severidade do processo inflamatório. De forma interessante, não houve correlação entre os níveis protéicos e de mRNA de MMP-13 em ambos os modelos, sugerindo uma regulação pós­transcricional da expressão de MMP-13 in vivo. Além disso, p38 e ERK MAPkinases, assim como NF- B foram ativadas nos dois modelos de doença periodontal, embora com cinética distinta; enquanto ativação de STAT3 e STAT5 foi verificada apenas no modelo de ligadura. Estes achados sugerem uma ativação diferencial de receptores celulares em cada forma de indução da doença periodontal, o que determina diferenças temporais e qualitativas nas redes de sinalização intracelular ativadas e influencia a regulação da expressão gênica de MMP-13 em cada modelo experimental

The hallmark of destructive periodontal disease progression is the overproduction of cytokines which promotes the increased expression of other inflammatory mediators such as, MMPs. MMP-13 is a collagenase of complex gene regulation that has been implicated on ECM degradation and bone resorption in several inflammatory conditions, including periodontal disease and rheumatoid arthritis. Regulation of gene expression requires the activation of several signaling pathways through receptor-ligand binding of external stimuli represented by bacterial antigens and/or host-derived cytokines. The complexity of the cytokine network established during periodontal disease progression results from the signaling pathways activated, which are determined by the nature of external stimuli. Thus, considering the fundamental role of signaling pathways on regulation of cytokine gene expression and the relevant role of MMP-13 in periodontal disease, this study evaluated the expression of MMP-13 and the signaling pathways activated during the course of two experimentallyinduced periodontal disease models. Expression of MMP-13 at mRNA and protein levels was evaluated by reverse transcription polymerase chain reaction (RT-PCR) and Western Blot, respectively. The activation kinetics of some signaling pathways that are related to the expression of inflammatory mediators was also verified by Western Blot. The two experimental models used were: LPS injections and placement of ligatures. Bi-weekly injections of Eschericia coli LPS were done into the palatal aspect of upper molars (30 µg per injection). Ligatures were placed at the cervical portion of both lower first molars. The control animals received injections of PBS vehicle on the palatal gingiva of upper molars, whereas no ligatures were placed on the lower molars. Samples were collected 5, 15 and 30 days after beginning of periodontal disease induction and processed for extraction of total RNA and protein, as well as routinely processed for histology/estereometry. A significant increase on the severity of inflammation was observed in both experimental models already at the 5-day period. However, the ligature model presented a significant decrease on the intensity of inflammation at the 30-day period, which was not observed with the LPS injection model. MMP-13 expression profile, as well as the kinetic of signaling pathways activated during periodontal disease were somewhat different according to each experimental model, however paralleled the severity of inflammation. Interestingly, there was no transcription-translation coupling for MMP-13 in both models, suggesting a post­transcriptional regulation of MMP13 expression in vivo. Moreover, p38 and ERK MAPkinases, as well as NF-kB were activated in both periodontal disease models, however with different kinetics, whereas activation of STAT3 and STAT5 was verified only on the ligature model. These findings suggest a differential activation of cellular receptors in each model of experimentally-induced periodontal disease, which results in temporal and qualitative differences on the signaling network and influences MMP-13 gene regulation in each experimental model